Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000899243-21-009474

Options or other derivatives

  • Chief Financial Officer acquired 400,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Mokari Atabak Chief Financial Officer 2021-03-01 Grant or award · Stock Option (Right to Buy) +400,000 400,000 D
Loading xslF345X03/doc4.xml…